| Product Code: ETC9961526 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) CNV (Choroidal NeoVascularization) Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) CNV (Choroidal NeoVascularization) Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) CNV (Choroidal NeoVascularization) Market - Industry Life Cycle |
3.4 United States (US) CNV (Choroidal NeoVascularization) Market - Porter's Five Forces |
3.5 United States (US) CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 United States (US) CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United States (US) CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 United States (US) CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) CNV (Choroidal NeoVascularization) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of age-related macular degeneration (AMD) in the US population |
4.2.2 Advancements in diagnostic technologies for early detection of choroidal neovascularization (CNV) |
4.2.3 Rising adoption of anti-VEGF therapies for CNV treatment |
4.3 Market Restraints |
4.3.1 High treatment costs associated with anti-VEGF therapies |
4.3.2 Limited access to specialized CNV treatment centers in certain regions of the US |
5 United States (US) CNV (Choroidal NeoVascularization) Market Trends |
6 United States (US) CNV (Choroidal NeoVascularization) Market, By Types |
6.1 United States (US) CNV (Choroidal NeoVascularization) Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 United States (US) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 United States (US) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Fluorescein AngiographyOptical Coherence Tomography, 2021- 2031F |
6.1.4 United States (US) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) CNV (Choroidal NeoVascularization) Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United States (US) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Anti-VEGF, 2021- 2031F |
6.2.3 United States (US) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Photodynamic Therapy, 2021- 2031F |
6.2.4 United States (US) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Thermal Laser, 2021- 2031F |
6.2.5 United States (US) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) CNV (Choroidal NeoVascularization) Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 United States (US) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United States (US) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 United States (US) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.5 United States (US) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) CNV (Choroidal NeoVascularization) Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United States (US) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 United States (US) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.4 United States (US) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By online Pharmacies, 2021- 2031F |
6.4.5 United States (US) CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) CNV (Choroidal NeoVascularization) Market Import-Export Trade Statistics |
7.1 United States (US) CNV (Choroidal NeoVascularization) Market Export to Major Countries |
7.2 United States (US) CNV (Choroidal NeoVascularization) Market Imports from Major Countries |
8 United States (US) CNV (Choroidal NeoVascularization) Market Key Performance Indicators |
8.1 Average time from CNV diagnosis to treatment initiation |
8.2 Number of ophthalmologists specializing in CNV treatment |
8.3 Patient adherence to prescribed CNV treatment regimen |
9 United States (US) CNV (Choroidal NeoVascularization) Market - Opportunity Assessment |
9.1 United States (US) CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 United States (US) CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United States (US) CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 United States (US) CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) CNV (Choroidal NeoVascularization) Market - Competitive Landscape |
10.1 United States (US) CNV (Choroidal NeoVascularization) Market Revenue Share, By Companies, 2024 |
10.2 United States (US) CNV (Choroidal NeoVascularization) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here